Mycobacterium fortuitum infection of ventriculoperitoneal shunt

Southern Medical Journal

Volumn 92, Issue 7, 1999, Pages 705-707

  Midani, Samir ^a,b   Rathore, Mobeen H ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COTRIMOXAZOLE;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; DEBRIDEMENT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYCOBACTERIUM FORTUITUM; ORAL DRUG ADMINISTRATION; PLEOCYTOSIS; POSTOPERATIVE INFECTION; SHUNT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; SPINA BIFIDA;

ADOLESCENT; AMIKACIN; ANTI-BACTERIAL AGENTS; CAUSALITY; CENTRAL NERVOUS SYSTEM INFECTIONS; CROSS INFECTION; DEBRIDEMENT; DRAINAGE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; MALE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VENTRICULOPERITONEAL SHUNT;

EID: 0032767824     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199907000-00009     Document Type: Article

References (12)

1. Hand WL, Sanford JP: Mycobacterium fortuitum - a human pathogen. Ann Intern Med 1970; 73:971-977
2. Dalovisio JR, Pankey GA: Problems in diagnosis and therapy of Mycobacterium fortuitum infections. Am Rev Respir Dis 1978; 117:625-630
3. Dalovisio JR, Pankey GA,Wallace RJ, et al: Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981; 3:1068-1074
4. Santamaria-Jauregui J, Sanz-Hospital J, Berenguer J, et al: Meningitis caused by Mycobacterium fortuitum. Am Rev Respir Dis 1984; 130:136-137
5. Burns JL, Malhotra U, Lingappa J, et al: Unusual presentations of nontuberculous mycobacterial infections in children. Pediatr Infect Dis J 1997; 16:802-806
6. Wells AQ, Agius E, Smith N: Mycobacterium fortuitum. Am Rev Tuber 1955; 72:53-63
7. Beck A: Mycobacterium fortuitum in abscesses of man. J Clin Pathol 1965; 18:307-313
8. Cott RE, Carter M, Sall T: Cutaneous disease caused by atypical mycobacteria, report of two chromogen infections and review of the subject. Arch Dermatol (Chicago) 1967; 95:259-268
9. Wallace RJ Jr, Swenson JM, Silcox VA, et al: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5:657-679
10. Clegg HW, Foster MT, Sanders WE, et al: Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis 1983; 147:427-433
11. Raad II, Vartivarian S, Khan A, et al: Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13:1120-1125
12. Wallace RJ Jr, Swenson JM, Silcox VA, et al: Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacteriun chelonei on the basis of in-vitro susceptibilities. J Infect Dis 1985; 152:500-514